Table of Contents
ISRN Dermatology
Volume 2012, Article ID 257059, 4 pages
http://dx.doi.org/10.5402/2012/257059
Research Article

Expression of Nuclear Factor Kappa B and Survivin in Psoriasis

1Department of Dermatology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey
2Department of Pathology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey

Received 1 October 2012; Accepted 3 November 2012

Academic Editors: C. Ferrándiz and S. Inui

Copyright © 2012 Kamer Gunduz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Krueger and C. N. Ellis, “Psoriasis—recent advances in understanding its pathogenesis and treatment,” Journal of the American Academy of Dermatology, vol. 53, no. 1, pp. S94–S100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Bowen, A. N. Hanks, K. J. Murphy, S. R. Florell, and D. Grossman, “Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias,” American Journal of Dermatopathology, vol. 26, no. 3, pp. 177–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Heenen and T. Simonart, “Apoptosis in psoriatic epidermis,” Journal of Cutaneous Pathology, vol. 35, no. 3, p. 346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. K. Kaufman and E. Fuchs, “It's got you covered: NF-κB in the epidermis,” Journal of Cell Biology, vol. 149, no. 5, pp. 999–1004, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Lippens, E. Hoste, P. Vandenabeele, P. Agostinis, and W. Declercq, “Cell death in the skin,” Apoptosis, vol. 14, no. 4, pp. 549–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Abdou and H. M. Hanout, “Evaluation of survivin and NF-κB in psoriasis, an immunohistochemical study,” Journal of Cutaneous Pathology, vol. 35, no. 5, pp. 445–451, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Markham, C. Mathews, S. Rogers et al., “Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy,” British Journal of Dermatology, vol. 155, no. 6, pp. 1191–1196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Simonetti, G. Lucarini, A. Campanati et al., “VEGF, survivin and NOS overexpression in psoriatic skin: critical role of nitric oxide synthases,” Journal of Dermatological Science, vol. 54, no. 3, pp. 205–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Fukuda and L. M. Pelus, “Survivin, a cancer target with an emerging role in normal adult tissues,” Molecular Cancer Therapeutics, vol. 5, no. 5, pp. 1087–1098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Chiodino, A. M. Cesinaro, D. Ottani et al., “Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin,” Journal of Investigative Dermatology, vol. 113, no. 3, pp. 415–418, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Li, L. Gao, Z. Shen et al., “Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris,” Archives of Dermatological Research, vol. 300, no. 8, pp. 425–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. F. K. Doger, E. Dikicioglu, F. Ergin, E. Unal, N. Sendur, and M. Uslu, “Nature of cell kinetics in psoriatic epidermis,” Journal of Cutaneous Pathology, vol. 34, no. 3, pp. 257–263, 2007. View at Publisher · View at Google Scholar · View at Scopus